By Brian Gleason in SLM — 10 Feb 2026

Neuroimmune Dysregulation: Inflammation as Lock-In, Not Side Effect

How the body becomes the jailer of the mind (SLM 4 of 10)

This is the fourth essay in our ten-part series on the Signal Loss Model. In SLM 1, we examined how recent psychiatric genomics challenge the idea that depression and anxiety are fixed diseases, pointing instead to shared biological vulnerabilities rooted in signal loss. In SLM 2, we explored how the brain's simulation machinery decouples from reality when environmental constraints disappear. In SLM 3, we showed why equally capable people break in different ways based on constraint timing. Here, we examine the biological mechanism that makes these patterns so treatment-resistant: inflammatory lock-in.

The Prison of Insight

Three different people, three different observations, the same wall:

Elena, 42, senior partner at a consulting firm, six months into finally prioritizing herself: "I know exactly what I need to do. I've read all the books, done the therapy, understand my patterns completely. But when I sit down to actually change something—meditate, set boundaries, even just pause—it feels like pushing against a wall. Not psychological resistance. Physical impossibility."

James, 52, eighteen months post-exit from the logistics company he built: "I thought selling would give me freedom to figure out what I actually want. Instead, I just feel... frozen. I'll start a new project, lose interest in three days. I have all the time in the world for self-reflection, but my brain just won't move. I understand I'm stuck. Understanding changes nothing."

Priya, 61, still in the C-suite role she's held for eight years: "My therapist keeps saying I need to 'process my emotions' and 'sit with discomfort.' I can sit with it fine. I can analyze it, understand where it comes from, see the whole pattern. But nothing shifts. It's like knowing the combination to a lock but the tumblers won't turn."

These are not people failing due to lack of willpower, insufficient insight, or resistance to change. They represent a modern diagnostic frustration I'll refer to as the "prison of insight." They can see over the wall, but they can't get out of the cell.

What they're experiencing is biological lock-in: a state where the immune system becomes the jailer of the mind, actively uninstalling the neurobiological capacity for change itself.

To understand why insight alone can't release them, we must follow the causal chain from abstract thought → cellular alarm system → frozen neural architecture.

Phase I: The Sentencing (When Simulation Signs the Warrant)

The jailer doesn't arrive by accident. It's summoned by the brain's own simulation machinery.

As we established in SLM 2, the brain does not distinguish between a real threat and a simulated one. When your Default Mode Network loops endlessly through catastrophic scenarios, for example modeling every way a negotiation could fail, rehearsing difficult conversations that may never happen, running disaster simulations in the 3 AM darkness, your body responds as if those threats are happening right now.

This isn't a quirk of perception. It's neurobiological reality: mental imagery activates the same primary visual cortex as physical perception (Kosslyn et al., 1999). The simulation is real to your stress biology.

Elena's strategy meetings aren't just cognitively demanding. They're issuing molecular warrants for a sustained stress response.

The Cellular Damage Cascade

Chronic psychological stress, including the sustained abstract cognitive stress from untethered simulation, causes measurable physical damage at the molecular level.

Glucocorticoid-induced oxidative stress: Sustained cortisol elevation creates oxidative stress throughout the body, particularly in high-energy-demand tissues like neurons. This isn't just "feeling stressed." It's literal molecular wear and tear (McEwen, 2007).

Mitochondrial dysfunction: The cellular power plants that generate ATP become damaged under chronic energetic demand. Mitochondria are exquisitely sensitive to stress; when they can't keep up with the allostatic load, they begin to fail structurally (Picard & McEwen, 2018).

DNA fragmentation and leakage: When mitochondria sustain damage, their double membranes become permeable. Mitochondrial DNA, which shouldn't be floating freely in the cell, leaks into the cytosol (the cellular fluid).

This damage pathway is bidirectional. It occurs both when simulation machinery loses its organizing target (James's post-achievement drift into existential rumination) and when it's chronically overdriven by unsustainable demands (Elena's years of modeling failure modes at cognitive altitude).

Different constraint timing, different phenomenology, but the same cellular injury.

The critical insight: This is literal cellular damage caused by thinking patterns. Abstract cognition has become concrete at the molecular level.

The Viral False Alarm

Here’s where the immune system enters the story.

Your body evolved sophisticated machinery to detect invasion. Specifically, the innate immune system has sensors designed to detect foreign (or misplaced) DNA appearing where it shouldn’t be: loose in the cytosol of your cells.

One of the central DNA-sensing systems is the cGAS–STING pathway:

cGAS (cyclic GMP–AMP synthase) detects double-stranded DNA in the cytosol
When cytosolic DNA is present, cGAS synthesizes a second messenger (cGAMP) that activates STING (Stimulator of Interferon Genes)
STING then triggers an antiviral alarm program (most notably type I interferon signaling and downstream inflammatory mediators) because that’s exactly what you’d want if the DNA really belonged to a virus (West et al., 2015; Ablasser & Chen, 2019).

The pathway is ancient, highly conserved across species, and very sensitive. It has to be; delayed response to real invasion can be fatal.

But the sensor isn’t a detective. It’s a smoke detector. It responds to DNA in the cytosol. That's it. And that creates a built-in vulnerability: when self-DNA escapes its normal compartments, the same alarm can be pulled.

This is where mitochondria enter the story. Under mitochondrial DNA stress, fragments of mitochondrial DNA can appear in the cytosol and engage this same cGAS–STING machinery, priming antiviral responses even in the absence of any infection.

Except there’s no virus to clear. No bacterial infection to resolve. Just ongoing cellular stress capable, under the right conditions, of producing ongoing DNA leakage and repeated immune activation. The system is responding as it should to the data it’s receiving. It’s just detecting the wrong threat.

The biological mechanism is direct: chronic cognitive arousal is a chronic mitochondrial stressor. This sustained stress forces mitochondrial DNA to escape into the cytosol. Once present, the cGAS-STING pathway detects it as a viral invasion and triggers a systemic antiviral alarm.

Elena’s immune system isn’t “confused.” It is responding with perfect fidelity to a false alarm generated and sustained by her own cognitive architecture.

Enter Inflammaging

Once cGAS-STING activates in response to chronic mitochondrial stress, it triggers what gerontologists call the senescence-associated secretory phenotype, or SASP (Glück et al., 2017; Hu et al., 2022; Coppé et al., 2010).

The term "inflammaging" was coined by immunologist Claudio Franceschi to describe a phenomenon observed in elderly populations: chronic low-grade inflammation that wasn't responding to any acute infection or injury, but instead seemed to be driving the aging process itself (Franceschi et al., 2000).

His core insight: biological aging isn't just about time passing, it's about inflammatory load accumulating.

In normal aging, cells gradually accumulate damage, become senescent (they stop dividing but don't die, thus "zombie cells"), and begin secreting inflammatory factors. This creates a self-amplifying feedback loop:

Inflammation damages more cells
Damaged cells become senescent
Senescent cells secrete more pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)
These cytokines damage additional cells
The cycle accelerates

Franceschi called this inflammaging: inflammation-driven acceleration of biological aging.

Constraint Architecture Age vs. Chronological Age

What the Signal Loss Model uniquely synthesizes is that inflammaging isn't just about chronological age. It's about constraint architecture age: How long and how intensely regulatory systems have operated beyond their sustainable capacity.

A 45-year-old executive after two decades of sustained cognitive constraint at altitude can resemble the immune profile of someone decades older. It's measurable through inflammatory biomarker panels: elevated IL-6, TNF-α, C-reactive protein (CRP), and, in research settings, markers consistent with increased senescent cell burden (Furman et al., 2019).

The SASP state doesn't require ongoing acute stress to persist. Once established, it becomes self-sustaining:

Senescent cells accumulate and continuously secrete inflammatory factors
These factors create systemic low-grade inflammation
Inflammation causes more cellular damage
More cells become senescent
The inflammatory load increases

This is biological aging in real-time, driven not by years but by stress load. And critically: once inflammaging establishes itself, it can persist even after the original stressor fades (Furman et al., 2019).

The jailer, once summoned, doesn't need further orders. It continues operating on its own authority.

But the persistence of inflammaging is not limited to the SASP chemical cycle. Recent neuroimmunology research has revealed a deeper layer: the brain's own regulatory cells can develop durable inflammatory memory.

Astrocytes (the most abundant glial cells in the CNS) do not merely react to inflammatory signals. Under sustained exposure to pro-inflammatory cytokines (particularly IL-1β and TNF), astrocytes undergo stable chromatin remodeling via a metabolic pathway involving ATP-citrate lyase (ACLY) and the histone acetyltransferase p300. This epigenetic reprogramming creates what amounts to a cellular "memory" of prior inflammation: upon subsequent challenge, these primed astrocytes mount an exacerbated pro-inflammatory response, even if the original stimulus was removed long ago (Lee et al., 2024).

This is a specific molecular mechanism by which the CNS writes its inflammatory history into the chromatin structure of its own cells.

A related line of investigation has identified the glucocorticoid receptor (NR3C1) as one regulator of whether this inflammatory memory forms. In developmental models, loss of NR3C1 function in astrocytes permits pro-inflammatory chromatin states to become permanently accessible (Park et al., 2025; Lee & Quintana, 2025). While the experimental evidence for this specific gatekeeper mechanism currently comes from early-life developmental windows (adult NR3C1 deletion did not reproduce the same enduring epigenetic alterations) the broader finding is significant for the Signal Loss Model. The glucocorticoid system, the very system chronically activated by the sustained stress of achievement architecture, is a known regulator of inflammatory memory formation.

Whether analogous mechanisms operate under chronic adult glucocorticoid exposure remains an open and testable question. But the implication is clear: the jailer may not merely sustain itself through ongoing chemical cycles. It may have written its authority into the cellular architecture of the brain itself.

Phase II: The Lock (Neurochemical Bars)

Once the jailer is summoned, it doesn't just stay in the periphery. Inflammation crosses the blood-brain barrier and hijacks the very molecules required for psychological freedom. This is where biological lock-in becomes structurally reinforced.

The inflammatory state creates neurochemical jail bars, specific disruptions to neurotransmitter systems that prevent adaptive change even when you intellectually understand what needs to happen.

The Kynurenine Pathway: Stealing Serotonin's Precursor

Under normal conditions, the amino acid tryptophan, obtained from diet, can be used to synthesize serotonin, a neurotransmitter involved in mood regulation, emotional stability, and stress resilience.

But when pro-inflammatory cytokines (particularly interferon-gamma and TNF-α) are elevated, they activate an enzyme called IDO (indoleamine 2,3-dioxygenase). IDO reroutes tryptophan away from serotonin production and into the kynurenine pathway instead (Dantzer et al., 2008; Schwarcz et al., 2012).

The consequences cascade:

Serotonin depletion: Less tryptophan available for serotonin synthesis means reduced baseline mood regulation capacity. This isn't "chemical imbalance" in the pop psychology sense. It's inflammatory hijacking of neurotransmitter precursors.

Regulatory substrate sequestration: The tryptophan diversion has a second, less obvious consequence. Under normal conditions, dietary tryptophan is also metabolized by commensal gut flora into ligands for the aryl hydrocarbon receptor (AHR) (specifically metabolites like indoxyl-3-sulfate) which cross the blood-brain barrier and act as critical regulatory constraints on glial pathogenicity. AHR activation in astrocytes suppresses NF-κB-driven pro-inflammatory gene expression; in microglia, AHR signaling promotes anti-inflammatory TGFα while inhibiting pro-inflammatory VEGF-B (Rothhammer et al., 2016; Rothhammer et al., 2018).

When the kynurenine pathway captures a larger share of systemic tryptophan under inflammatory IDO activation, it potentially starves the gut microbiome of the substrate needed to produce these AHR-active metabolites. The result is a self-undermining signal failure: inflammation doesn't just generate neurotoxic byproducts, it simultaneously depletes the anti-inflammatory brakes that normally keep astrocytes and microglia in a non-pathogenic state. The system is consuming the very inputs required for its own regulation.

While the complete causal chain, from IDO-driven tryptophan sequestration to failure of AHR-mediated glial suppression, remains an inference awaiting direct longitudinal demonstration, it is consistent with the broader pattern of inflammation as self-sustaining lock-in rather than transient side effect.

Neurotoxic metabolite production: Some kynurenine breakdown products (particularly quinolinic acid) are directly neuroactive and can be neurotoxic at elevated levels. Quinolinic acid is an NMDA receptor agonist, increasing excitatory glutamate signaling. This contributes to anxiety, agitation, and cognitive “noise” (Schwarcz et al., 2012).

Excitotoxicity: Elevated glutamate under inflammatory conditions can contribute to excitotoxic stress—too much excitatory signaling overwhelming neurons’ capacity to regulate.

The kynurenine pathway isn’t an obscure side pathway. It’s already the primary route for tryptophan metabolism, and under inflammatory conditions, it can capture an even larger share. The system designed to produce stability instead produces neurotoxicity.

Dopamine Suppression: Draining Motivation at the Source

Inflammation doesn't just affect serotonin. Pro-inflammatory cytokines also reduce dopamine synthesis in the basal ganglia, particularly in the ventral striatum (nucleus accumbens), the brain's reward center (Felger & Lotrich, 2013).

The mechanism involves (Felger & Miller, 2012):

Inflammatory cytokines reducing tetrahydrobiopterin (BH4), a critical cofactor for dopamine synthesis
Direct cytokine effects on dopaminergic neurons
Increased presynaptic dopamine uptake (greater reuptake), reducing synaptic availability

The result: incentive salience collapse. Even potentially rewarding activities stop registering as worth pursuing. This is the neurochemical substrate of anhedonia. Not "low dopamine" in some vague sense, but inflammation-driven suppression of the brain's motivation circuitry.

We'll examine pursuit-reward decoupling in depth in SLM 5. For now, the key point: inflammation doesn't just block rewiring (which we'll detail in Phase III), it also removes the motivational pull that would drive you to attempt change in the first place.

BDNF Suppression: Removing the Biological Grease

The most critical consequence of inflammatory lock-in is the suppression of Brain-Derived Neurotrophic Factor (BDNF).

BDNF is not just "a neuroplasticity molecule." It's a central regulator of:

Synaptic potentiation (strengthening connections between neurons)
Dendritic spine formation (creating new connection points)
Neuronal survival under stress
Adult neurogenesis involved in the birth of new neurons in the hippocampus

Pro-inflammatory cytokines (particularly IL-1β and TNF-α) directly downregulate BDNF expression (Calabrese et al., 2014). When BDNF levels drop, the brain's fundamental capacity to form new neural connections is compromised.

This is why Priya can know the combination to her internal lock but find the tumblers physically won't turn. BDNF is the biological "grease" for those tumblers. Without adequate BDNF, the neural machinery for behavioral change is mechanically jammed.

The neurochemical bars are in place:

Serotonin precursors diverted to neurotoxic pathways
Dopamine synthesis suppressed
BDNF levels inadequate for plasticity
Excitatory tone elevated, stability reduced

The brain hasn't become "broken." It's operating in an environment biochemically hostile to change.

Phase III: When the Brain Can't Rewire

Neuroplasticity (the brain's ability to reorganize itself by forming new neural connections) is not a metaphor for "being open-minded." It's a specific set of biological processes involving:

Long-term potentiation (LTP): Synaptic strengthening that forms the cellular basis of learning and memory
Dendritic spine formation: Physical creation of new connection points between neurons
Adult neurogenesis: Birth of new neurons, particularly in the hippocampus
Synaptic pruning: Removal of unused connections to optimize neural networks

All of these processes depend on:

Adequate BDNF signaling
Healthy mitochondrial function (energy for synapse formation)
A non-inflammatory neurochemical environment
Proper microglial function (brain's immune cells in surveillance mode, not activated)

Under inflammatory lock-in, every single one of these mechanisms is impaired. The lock isn't just engaged, it's structurally reinforced at the synaptic level.

Microglial Priming: When Brain Immune Cells Turn Hostile

Microglia are the brain’s resident immune cells. In healthy states, they operate in a surveying mode: monitoring the environment, clearing debris, and supporting synaptic function.

But under chronic peripheral inflammation, cytokine signals can reach the brain and its barriers and shift microglia toward a more inflammatory, activated state (Miller & Raison, 2016; Yirmiya & Goshen, 2011).

Activated microglia can:

Release inflammatory mediators that amplify central inflammation
Disrupt synaptic function and plasticity
Become more reactive to subsequent stressors

The brain's immune cells have switched from supportive maintenance to active hostility toward new connection formation.

Elena's sensation of "physical impossibility" when attempting to change is neurobiologically plausible: her neuroimmune state is working against the synaptic reorganization behavioral change requires.

Hippocampal Neurogenesis Suppression

The hippocampus, which is critical for memory formation, contextual learning, spatial navigation, and emotional regulation, retains the capacity to generate new neurons in adulthood. Stress biology can meaningfully alter its structure and plasticity. This wasn’t always accepted; the recognition of adult hippocampal neurogenesis reshaped neuroscience in the late 20th century.

Hippocampal neurogenesis is important for:

Pattern separation (distinguishing similar experiences)
Contextual fear extinction (unlearning threat associations)
Cognitive flexibility
Emotional regulation capacity

Chronic stress and inflammation suppress this process (Koo & Duman, 2008; Lucassen et al., 2014).

The mechanisms:

Sustained cortisol elevation directly suppresses neuronal stem cell proliferation
Pro-inflammatory cytokines (particularly IL-1β) inhibit neurogenesis
Reduced BDNF means newborn neurons don't survive even if they're generated
Oxidative stress damages the neurogenic niche (the cellular environment where new neurons are born)

At the systems level, MRI meta-analyses report measurable hippocampal volume reduction in major depression, especially with greater illness burden over time (Videbech & Ravnkilde, 2004).

So the claim here isn’t that MRI “proves” inflammation as the cause. It’s that we have a plausible causal pathway at the cellular level. And the imaging findings are consistent with the downstream consequence: a hippocampus operating under conditions that are less favorable for learning, context-updating, and emotional recalibration.

Synaptic Plasticity Disruption

Even if you could generate new neurons and avoid excessive pruning, the fundamental cellular mechanism of learning, long-term potentiation (LTP), is disrupted under inflammatory conditions.

LTP is the process by which synapses strengthen when neurons fire together repeatedly. It's the cellular implementation of "neurons that fire together, wire together." Without functional LTP, learning new patterns becomes mechanistically constrained: harder to encode, harder to stabilize, and easier to lose.

Inflammatory cytokines can impair LTP induction through multiple pathways (Pickering & O'Connor, 2007; Yirmiya & Goshen, 2011):

IL-1β can block the molecular cascade required for synaptic strengthening
TNF-α can alter AMPA receptor trafficking and synaptic receptor composition in ways that destabilize normal plasticity
Elevated oxidative stress damages the signaling machinery
Reduced neurotrophic support (including BDNF) makes it harder for plastic changes to consolidate

The result: even when you consciously try to learn new behavioral patterns (e.g., when you practice meditation, attempt to set boundaries, rehearse different responses), the synapses are operating in a biochemical environment that makes those patterns harder to encode and harder to hold.

James’s brain won’t “move.” Motivation is part of the story and dopamine suppression from Phase II doesn’t help. But the deeper problem is mechanical: the synaptic machinery required for rewiring is biologically jammed.

This creates the Signal Loss Feedback Loop:

Untethered Cognition triggers mitochondrial damage.
Cellular Alarm (cGAS-STING) triggers systemic inflammation.
Neurotransmitter Hijacking reduces cognitive control.
Structural Lock-In prevents the brain from learning new exit patterns.
Decreased Control leads to worse simulation collapse, and the cycle repeats.

The inflammatory lock-in is complete:

New neurons aren't being born
Existing synapses can't strengthen
Microglia are actively hostile to new connections
The cellular basis of learning is suppressed

This is why standard therapeutic interventions fail so predictably in this population. They're attempting to produce neural reorganization in a brain that has been rendered biologically incapable of reorganizing.

Phase IV: Why Standard Keys Don't Work

Now we can explain the treatment resistance that defines this population, and why Elena, James, and Priya have tried multiple evidence-based interventions without sustainable improvement.

When the inflammatory jailer controls the neuroplastic lock mechanism, standard therapeutic keys cannot turn it. The keys aren't poorly designed. The lock's internal mechanics have been altered.

Talk Therapy: Insight Without Implementation

Cognitive Behavioral Therapy, psychodynamic therapy, Acceptance and Commitment Therapy, even trauma-focused approaches like EMDR, all share a fundamental assumption: the brain can rewire maladaptive patterns when provided with new information, reframed narratives, or exposure to corrective experiences.

This assumption is valid when neuroplasticity is intact.

But as we detailed in Phase III, inflammatory lock-in suppresses:

BDNF (required for synaptic strengthening)
Hippocampal neurogenesis (required for pattern separation and contextual updating)
LTP (required for consolidating new learning)

Talk therapy provides the information for change. It offers accurate maps of maladaptive patterns, identifies cognitive distortions, names relational wounds, provides corrective frameworks. But information alone cannot rewire circuits when the biological substrate for rewiring is unavailable.

Priya's experience is paradigmatic: "I can analyze it, understand where it comes from, see the whole pattern. But nothing shifts." She has the insight. The insight is accurate. The insight is inert because her brain cannot translate understanding into neural reorganization.

This isn't therapy failure. It's biology operating outside the parameters therapy was designed for.

Meditation and Mindfulness: Awareness Without Regulation

Meditation-based interventions have robust evidence for efficacy in reducing anxiety, improving attentional control, and strengthening prefrontal regulation of the Default Mode Network (Tang et al., 2015).

They work by:

Building new attentional habits through repeated practice
Strengthening prefrontal-amygdala connectivity
Reducing Default Mode Network dominance during task engagement
Increasing interoceptive awareness

But every single one of these outcomes requires neuroplasticity. Meditation builds new neural patterns through practice, which requires synaptic consolidation, BDNF signaling, and non-inflammatory conditions.

Under inflammatory lock-in, meditation practice feels exactly as Elena described: "pushing against a wall." The awareness component works. You can observe your thoughts, notice your breath, recognize when the mind wanders. But the regulatory capacity doesn't build.

It's like doing strength training while a drug blocks muscle protein synthesis. The effort is real, the intention is correct, but the biological machinery required for adaptation isn't responding.

Some meditation practitioners in this population report the practice actually worsens their state: increased agitation, heightened self-criticism, amplified awareness of their inability to change (Britton, 2019). This makes mechanistic sense: you're increasing interoceptive precision (awareness of internal states) while the capacity to regulate those states remains biologically constrained.

SSRIs: Incomplete Mechanism

Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line pharmaceutical treatment for depression and anxiety. They work by blocking the reuptake of serotonin from the synaptic cleft, increasing serotonin availability for neurotransmission.

But that’s not their only mechanism. SSRIs also, over four to six weeks, upregulate BDNF expression (Duman & Monteggia, 2006). And BDNF isn’t just a side effect of antidepressants, it’s a key transducer of their therapeutic effects (Björkholm & Monteggia, 2016). This is why they take time to work: the therapeutic effect depends on restoring neuroplasticity through BDNF, not just acute serotonin availability.

The problem under inflammatory lock-in: inflammation can blunt SSRI response by pushing the biology in the opposite direction.

Specifically:

Inflammation continues suppressing BDNF despite SSRI-induced upregulation attempts
The kynurenine pathway (from Phase II) continues diverting tryptophan away from serotonin synthesis, limiting the substrate available
Inflammatory signaling disrupts serotonin receptor function and downstream cascades

This explains a well-established clinical finding: elevated inflammatory markers predict SSRI non-response (Haroon et al., 2018). Roughly 30–50% of patients don't respond adequately to first-line antidepressants (Rush et al., 2006), and this treatment resistance correlates strongly with IL-6, TNF-α, and CRP levels (Haroon et al., 2018).

It's not that SSRIs don't work. It's that inflammation creates a biological environment where their mechanism of action is insufficient to overcome the opposing forces.

Exercise, Nutrition, Sleep: The Plasticity Catch-22

Physical exercise, anti-inflammatory nutrition, and sleep optimization all reduce inflammatory markers when implemented consistently (Gleeson et al., 2011; Irwin, 2015). The evidence is robust.

But here's the catch-22 that Elena, James, and Priya all face: Implementing these interventions requires sustained behavioral change. Sustained behavioral change requires neuroplasticity. Neuroplasticity is suppressed by the inflammation these interventions would address.

You need plasticity to implement the changes that restore plasticity.

This isn't lack of knowledge; all three know exercise would help. It isn't lack of resources; all three have gym access, can afford quality food, have the time. It's that the biological substrate for sustaining new behavioral patterns is unavailable.

Someone might manage three days of morning runs, then the pattern collapses. They will berate themselves for their lack of willpower. But consider that without neuroplasticity, the new routine can't consolidate into habit. It remains effortful, fragile, and the system reverts.

The inflammatory jailer doesn't just lock existing patterns in place. It prevents the installation of new ones.

The Clinical Implications

This mechanistic understanding clarifies why the "prison of insight" population is so frustrated with conventional treatment:

They've tried therapy. It provided insight but not change.
They've tried meditation. It increased awareness but not regulation.
They've tried SSRIs. They either didn't respond or had partial, temporary effects.
They've tried "lifestyle interventions." They couldn't sustain them.

The standard clinical interpretation? "Patient is resistant to treatment," "patient isn't ready to change," "patient lacks commitment."

The mechanistic reality: the patient is experiencing biological lock-in where the neuroplastic capacity for change has been suppressed by inflammatory processes.

This isn't treatment failure due to poor therapeutic technique or patient non-compliance. It's attempting neural reorganization in a brain rendered biologically incapable of reorganizing. The lock is engaged. The standard keys don't fit because the internal mechanism has been altered.

What's needed isn't a better version of the same key. It's a reset of the lock mechanism itself.

Phase V: The Vagal Brake Failure (How the Jailer Becomes Self-Sustaining)

Every jail has a security bypass. If triggered, this mechanism forces the system to release its hold. In the human body, that bypass is the vagus nerve.

But under chronic stress and inflammatory lock-in, this natural "brake" on inflammation becomes dysregulated, mechanically disabling the anti-inflammatory reflex and forcing the inflammatory state to sustain itself long after the original stressors resolve.

This explains why James remains "frozen" eighteen months post-exit, despite the removal of achievement pressures that initially drove his signal calibration loss. The inflammatory jailer, once summoned, has disabled its own override mechanism.

The Cholinergic Anti-Inflammatory Pathway

Your body has an elegant anti-inflammatory regulation system that operates through the vagus nerve: the Cholinergic Anti-Inflammatory Pathway (CAP).

The mechanism works like this (Tracey, 2002; Pavlov & Tracey, 2005; Wang et al., 2003):

The vagus nerve modulates immune activity in organs including the spleen, liver, and gut
Vagal efferent signaling releases acetylcholine
Acetylcholine binds to α7 nicotinic receptors on immune cells (macrophages, dendritic cells) (Gallowitsch-Puerta & Tracey, 2005)
This binding actively suppresses pro-inflammatory cytokine release (particularly TNF-α, IL-1β, IL-6)
Result: inflammatory responses stay contained and time-limited

When vagal tone is healthy (often approximated by HRV or heart rate variability), this brake is available. Inflammatory responses activate to clear threats, then shut down. The system returns to baseline.

This is “the inflammatory reflex,” a homeostatic mechanism as fundamental as blood pressure regulation or temperature control. But it depends entirely on vagal function. And vagal function is intensely sensitive to chronic stress.

Stress-Induced Vagal Decline

The same untethered simulation loops that produce cellular damage (Phase I) also dysregulate autonomic balance.

When your Default Mode Network is stuck modeling threats (our usual examples: running disaster scenarios, catastrophizing about legacy, rehearsing failure modes), your sympathetic nervous system (fight/flight) stays activated. This is measurable arousal: elevated heart rate, reduced heart rate variability, sustained sympathetic tone.

The consequence: vagal tone declines (Thayer & Lane, 2009; Kemp & Quintana, 2013).

Low HRV is strongly associated with depression, anxiety, and PTSD across hundreds of studies. But it's not just correlation. There’s a plausible mechanism: Low vagal tone → Cholinergic Anti-Inflammatory Pathway shutdown → inflammatory cytokines lose regulation → inflammation becomes unchecked (Tracey, 2002; Pavlov & Tracey, 2005; Wang et al., 2003).

This creates a vicious cycle:

Chronic stress → low vagal tone → CAP impairment → inflammation rises
Inflammation → further stress biology → vagal tone decreases further
The system locks into a state of chronic inflammation because the homeostatic override is gone

The system is now self-perpetuating.

Even when the external stressors are removed (James sells his company, constraint is lifted), if vagal tone remains suppressed, the CAP remains offline, and inflammation persists autonomously.

The jailer doesn't need ongoing orders. It has disabled its own security bypass.

Why Vagal Tone Can't Be "Thought" Into Recovery

You cannot cognitively regulate your way to higher HRV. Vagal tone is governed by subcortical, autonomic processes that respond to embodied experience, not cortical reasoning.

What can support vagal tone and parasympathetic recovery:

Physical safety cues: environments that reduce threat detection and allow the body to downshift
Reliable social co-regulation: contact with regulated people through voice, facial expression, proximity, rhythm, and predictable presence
Slow, diaphragmatic breathing: respiratory patterns that can increase vagally mediated HRV
Movement and proprioception: body-in-space grounding through walking, stretching, yoga, strength work, or somatic practice
Predictable ritual and structure: repeated patterns that reduce uncertainty and lower the burden of constant threat scanning

What does NOT increase vagal tone:

Understanding that you should relax
Cognitive reframing of stressors
Insight into autonomic dysregulation
Willpower or intention

This is why purely cognitive interventions fail to address inflammatory lock-in. They're attempting to regulate a dysregulated autonomic system through cortical pathways alone, like trying to lower your blood pressure by thinking about it.

Elena can understand intellectually that she needs to downregulate. That understanding doesn't activate her vagus nerve. James can recognize his nervous system is stuck in threat mode. Recognition doesn't restore vagal tone.

The lock mechanism has been altered at the autonomic level. Standard keys—cognitive, insight-based—can't reach it.

Phase VI: The Key (Psychedelics as Autonomic Reset)

Now we can understand why psychedelic-assisted therapy sometimes works when other interventions fail. And equally important, why it often does not work when integration architecture is inadequate.

A clarification before we continue: this is not an argument against mystical experience, ego dissolution, spiritual insight, beauty, awe, grief, communion, or the strange and often untranslatable moments that make psychedelic work matter from the inside. Those experiences can be central. They may be the part a person remembers for the rest of their life.

But they are not the layer of the mechanism we are isolating here. In SLM 4, the question is not what the opening means. The question is what makes the opening biologically possible after the system has been locked.

The neurobiological claim is that psilocybin can initiate a two-stage autonomic reset. First, an acute sympathetic surge pushes the system into high activation. Then, as the acute state resolves, a parasympathetic rebound may re-engage vagal regulation, restore anti-inflammatory braking, and reopen the biological capacity for change.

The mystical experience may be the subjective face of the opening. The autonomic reset is one plausible biological route by which the opening becomes available. The reset does not “cure” the person. It disables the inflammatory jailer long enough for the lock mechanism to function again.

But the window it opens is time-limited.

Stage 1: The Sympathetic Surge

As psilocin (the active metabolite of psilocybin) enters circulation and crosses the blood-brain barrier, it produces acute physiological arousal:

Heart rate increases
Blood pressure rises
Pupil dilation (mydriasis)
Subjective experience of activation, sometimes anxiety

This is the sympathetic surge: cardiovascular arousal that peaks during the acute psychedelic experience (Hasler et al., 2004). Neurobiologically, this represents significant physiological demand. The system is being pushed into high activation. This stage is not the therapeutic mechanism. It's the setup for what follows.

Stage 2: The Parasympathetic Rebound (The Protocol Premise)

As psilocin clears from the system, the autonomic nervous system rebounds toward a dominant parasympathetic state. This is more than a return to baseline; it is a profound shift in vagal availability that re-engages the anti-inflammatory brake.

Here’s what we can say without overreaching:

During the acute psychedelic state, heart-rate dynamics shift in consistent, quantifiable ways, including changes in high-frequency HRV and related features (Rosas et al., 2023).
Autonomic dynamics during the experience are not just epiphenomena: in a DMT study (a structurally related tryptamine psychedelic), measures of autonomic activity correlated with peak experiences and predicted increases in well-being two weeks later (Bonnelle et al., 2024).

What remains a hypothesis—plausible, but not yet proven as a general rule for psilocybin—is the stronger claim that baseline resting HRV remains elevated for many weeks after a single session. The direction of travel is suggestive, but the long-duration “vagal rebound” result should be framed as an active research question rather than a settled finding.

If the rebound model is right, the mechanism matters: When vagal tone increases → the Cholinergic Anti-Inflammatory Pathway becomes more available → inflammatory cytokine production is more constrained → the inflammatory jailer steps away.

The Anti-Inflammatory Cascade

The autonomic reset triggers downstream anti-inflammatory effects:

CAP reactivation: Restored vagal availability means acetylcholine-mediated suppression of pro-inflammatory cytokine release from immune cells can reassert itself (Tracey, 2002; Pavlov & Tracey, 2005; Flanagan & Nichols, 2018; Szabo, 2015)

BDNF upregulation becomes possible: With inflammation reduced, the opposing force suppressing BDNF expression decreases. BDNF levels can now rise more readily in response to the serotonergic stimulation psilocybin provides.

Neuroplastic window opens: Elevated BDNF + reduced inflammatory signaling = the biological conditions for synaptic reorganization are temporarily restored.

This is why psychedelics plausibly open a time-limited window for therapeutic work. They don’t produce permanent changes through the acute experience alone. They temporarily restore the biological conditions required for rewiring, conditions that inflammatory lock-in had suppressed.

If you don’t use that window strategically, it closes.

The Gut-Vagus Hypothesis (Speculative but Plausible)

There’s an intriguing additional mechanism that remains speculative but is consistent with available evidence: the “gut-vagus backdoor.”

Psilocin circulates systemically throughout the body. The gastrointestinal tract is densely populated with serotonin (5-HT) receptors. The gut is also extensively innervated by the vagus nerve (Browning & Travagli, 2014).

The hypothesis: psilocin binding to 5-HT receptors in the gut may directly stimulate vagal afferents, contributing to autonomic recalibration from the periphery upward—a “backdoor” route to vagal activation.

Evidence we have:

Psilocin circulates systemically
5-HT receptors are densely distributed in the GI tract
The vagus extensively innervates the gut
Autonomic dynamics during the experience relate to downstream benefit

Evidence we don’t have:

Direct proof this peripheral route is primary (versus central brain-down mechanisms)
Mechanistic isolation of gut-vagus contribution versus other pathways

Most likely: both central and peripheral pathways contribute to the autonomic reset.

Regardless of the precise route, the functional outcome is the same claim: psilocybin can temporarily restore autonomic balance, which permits anti-inflammatory regulation, which opens a neuroplastic window.

The jailer steps away. The lock mechanism resets to a functional state. The tumblers can turn again.

But only temporarily.

Why the Window Closes

The reset is time-limited. Neurotrophic signaling is transient unless it’s stabilized by environmental and behavioral inputs. Inflammatory suppression depends on maintained vagal function, and vagal function is sensitive to the same stress ecology that summoned the jailer in the first place.

Without strategic use of the window, without installing new patterns while plasticity is restored, the system can revert:

External constraints that drove initial stress remain unchanged
Behavioral patterns that suppress vagal function re-establish
Simulation machinery returns to untethered loops
Cellular stress resumes → mtDNA leakage → cGAS-STING reactivation
Inflammation returns → BDNF suppression returns → lock re-engages

This is why so many retreat experiences fail to produce lasting change. The acute psychedelic session opens the window beautifully. Then people return to the same lives, relationships, work patterns, and cognitive habits that summoned the jailer in the first place.

Within months (often weeks), many are back at baseline. The window has closed. The jailer has returned.

The reset is not the release. It’s the opening of the cell door. Whether you walk through it, and what environment you walk into, determines whether freedom is sustained or temporary.

Phase VII: Scaffolding the Release (Integration Architecture)

The neuroplastic window opens. The inflammatory jailer has stepped away. BDNF levels are rising. The biological conditions for change are temporarily restored.

Now what?

The question isn't whether you can change during this window. You can. That's what the autonomic reset accomplishes. The question is: what patterns will you install, and will they remain stable after the window closes?

The acute experience can be powerful, and its intensity often predicts benefit. But long-term recovery isn’t guaranteed by mystical intensity, the profundity of the insights, or the subjective sense of transformation during the session. Those factors matter. But they’re not self-executing, and the session isn’t the finish line. It’s the opening. Durable change depends on integration architecture: structured practices during and after the neuroplastic window that install new regulatory patterns and prevent the system from reverting to inflammatory lock-in.

Without scaffolding, Elena, James, and Priya return to the same environmental constraints, relational dynamics, and cognitive loops that summoned the jailer initially. The window closes. The patterns revert. The jailer returns.

Integration isn't optional. It's mechanistically necessary.

The Biological Requirements

Once inflammatory lock-in has been triggered, the body will default back to inflammatory lock-in unless it receives repeated, concrete signals of safety and regulation. These aren't preferences or "self-care" in the casual wellness sense. They are control inputs: specific practices that maintain vagal tone, suppress inflammatory signaling, and keep the Cholinergic Anti-Inflammatory Pathway active.

What the nervous system needs:

Sustained vagal stimulation (to keep CAP functioning)
Embodied reality constraint (to prevent simulation decoupling)
Mammalian co-regulation (to provide autonomic safety signals)
Predictable structure (to reduce threat detection)
Moderate physical engagement (anti-inflammatory without overtraining stress)

These aren't lifestyle suggestions. They're the biological mechanisms that prevent inflammatory recurrence.

Vagal Tone Training: Maintaining the Brake

The Cholinergic Anti-Inflammatory Pathway only functions when vagal tone remains elevated. Vagal tone doesn't maintain itself. It requires ongoing stimulation through specific practices:

Slow, diaphragmatic breathing: Direct vagal nerve stimulation through respiratory-cardiac coupling. Slow breathing (5-6 breaths per minute) increases HRV measurably and acutely (Gerritsen & Band, 2018). This isn't "relaxation breathing" in a vague sense; it's mechanistic vagal activation.

Daily ritual structure: Predictable patterns reduce the nervous system's need for threat scanning. When the day's structure is known, autonomic resources don't need to be allocated to vigilance. Rituals create psychological safety that translates to physiological safety (Hobson et al., 2018).

Coherent time architecture: Not just "having routines," but designing daily rhythms that respect ultradian cycles and prevent the chronic overextension that drives HPA axis dysregulation.

These practices must be daily to maintain effect. Vagal tone is a state variable, not a trait. It decays without maintenance.

Embodied Reality Constraint: Re-Tethering Simulation

As we established in SLM 2, simulation machinery decouples from reality when environmental constraints fail. The untethered simulation then drives the cellular stress that triggers inflammatory lock-in (Phase I).

Integration must re-establish concrete, physical reality constraints that force simulation to calibrate against feedback:

Somatic practices: Yoga, Somatic Experiencing, Feldenkrais, and (at Nāhua) equine-assisted therapy all provide bottom-up regulation through interoception (internal body awareness) and proprioception (spatial positioning) (van der Kolk, 2015; Payne et al., 2015).

These aren't just "body awareness exercises." They're practices that:

Ground abstract cognition in physical sensation
Provide immediate, non-verbal feedback on autonomic state
Make implicit regulatory patterns explicit and therefore modifiable
Anchor identity in embodied presence rather than narrative abstraction

Equine-assisted therapy specifically: Horses are prey animals with highly sensitive threat detection. When your autonomic state shifts toward sympathetic activation (even subtly) horses respond immediately through postural changes, distance regulation, or attention shifts. This provides real-time biofeedback on your nervous system state that you cannot fake or cognitively override.

Working with horses during the neuroplastic window makes autonomic patterns visible and modifiable in ways talk therapy cannot access.

Goal-directed physical engagement: Not just exercise, but activities with concrete stakes and immediate feedback. Building something. Navigating terrain. Tasks where success and failure are unambiguous and consequences are embodied.

This re-establishes the constraint architecture simulation machinery requires to remain calibrated.

Social isolation increases inflammatory gene expression. Positive social connection reduces it. The mechanism isn't purely psychological. It's autonomic and immunological (Eisenberger & Cole, 2012; Kok et al., 2013).

Mammalian co-regulation: Human nervous systems do not regulate in isolation. Polyvagal Theory (Porges, 2011) is one influential, though contested, framework for describing how social cues of safety may shape autonomic state. When you are in the presence of another regulated nervous system, your own body can receive cues (through tone, facial expression, proximity, rhythm, and predictability) that reduce threat detection and support parasympathetic recovery.

This isn’t about having lots of friends or being extroverted. It’s about repeated exposure to reliable social safety cues; being in physical proximity to regulated nervous systems often enough that your autonomic baseline can begin to shift.

The upward spiral: Kok et al. (2013) demonstrated that positive social connection increases HRV, and increased HRV makes positive social connection easier to access. The relationship is bidirectional and self-reinforcing.

During the neuroplastic window, social connection practices aren't just emotionally supportive, they're anti-inflammatory control inputs.

Physical Activity: Dose Matters

Moderate physical activity is robustly anti-inflammatory. Excessive physical activity is pro-inflammatory (Gleeson et al., 2011). The key variable: whether the activity stays within recovery capacity or exceeds it.

During the integration window:

Daily moderate movement (walking, gentle strength training, swimming)
Avoid chronic high-intensity training that drives cortisol elevation
Prioritize activities that provide proprioceptive grounding over pure cardiovascular stress

The goal is to maintain anti-inflammatory biology while providing embodied constraint. This is not about fitness optimization.

The Five-Week Window: Why This Duration Matters

At Nāhua, the residential retreat is followed by five weeks of structured integration support. This duration is calibrated to the convergent timelines for BDNF stabilization, HRV trait consolidation, and behavioral pattern installation, while remaining practical for a post-retreat protocol guests can actually live with.

During this window, we're not providing "aftercare" in the conventional sense. We're providing the biological scaffolding to ensure new patterns install while the system is permissive to change, and to prevent the inflammatory lock-in from re-establishing before those patterns stabilize.

Without this structured support:

BDNF elevation decays
HRV improvements fade
New practices don't consolidate into habit
Environmental stressors reactivate cellular stress
mtDNA leakage resumes → cGAS-STING reactivates → inflammatory lock-in returns
The jailer returns. The lock re-engages.

The biological window is a gift. Integration architecture is how you use it before it closes.

Scope and Limitations

Before closing, several critical caveats about what Neuroimmune Dysregulation does and does not claim.

This Model Does NOT Claim:

Inflammation causes all depression. That would be absurd reductionism. Depression is heterogeneous. Many people experience depressive episodes without elevated inflammatory markers. Many inflammatory conditions don't necessarily produce depression. The relationship is not deterministic.

SLM explains all treatment-resistant conditions. It doesn't. SLM describes a specific population: high-functioning adults experiencing signal loss patterns where chronic abstract stress drives biological lock-in. This is not a universal model of psychopathology.

Inflammation is the only mechanism in SLM. The Signal Loss Model integrates three mechanisms: untethered cognition (SLM 2), neuroimmune dysregulation (this essay), and pursuit-reward decoupling (SLM 5). None is sufficient alone. All three must be addressed. UC + ND + PRD = SLM.

Our population represents all psychological distress. Many people never develop inflammatory lock-in despite high achievement stress. Baseline genetic stress biology varies (as we established in SLM 1 through the Grotzinger genomics). Relational buffers, embodied practices, constraint diversity, and natural recovery capacity all modulate expression.

This Model DOES Claim:

For high-functioning adults experiencing signal loss patterns (untethered simulation + chronic stress from achievement architecture):

Inflammatory lock-in is the mechanism that makes psychological patterns persistent. Not just correlated with treatment resistance, a plausible causal driver of it through neuroplasticity suppression.
Standard interventions fail systematically when attempted during inflammatory lock-in because the biological substrate for change is mechanically unavailable.
Psychedelic-assisted therapy creates a time-limited neuroplastic window by shifting autonomic balance and reducing inflammatory pressure—but the window closes without integration architecture.
Long-term recovery often requires maintaining anti-inflammatory biology through embodied practices that keep vagal tone elevated and the Cholinergic Anti-Inflammatory Pathway active.

The Role of Genetics and Environment

The genetic variants we discussed in SLM 1 (prediction error and plasticity genes associated with internalizing disorders) modulate vulnerability to inflammatory lock-in. They don't determine it.

Environmental factors matter profoundly:

Quality of relational networks (co-regulation availability)
Access to embodied constraint (physical engagement with reality)
Diversity of identity anchors (not exclusively achievement-based selfhood)
Baseline stress load and recovery capacity
Early-life stress history (shapes inflammatory set-points)

Some people operate under enormous achievement constraint for decades without developing inflammatory lock-in. Others develop it with less extreme stress exposure. Neuroimmune Dysregulation explains the mechanism when it does occur, not why some are protected.

This is a comprehensive framework for a specific population, with clearly defined scope boundaries. It is not a universal theory in disguise.

Closing: The Three-Level Collapse

Neuroimmune Dysregulation explains why Elena, James, and Priya experience insight as inert. Their brains are not refusing to change. Under inflammatory lock-in, they have become biologically functionally incapable of change.

The jailer, summoned by untethered simulation and chronic stress, has uninstalled the neuroplastic machinery required for rewiring. BDNF is suppressed. Neurogenesis is blocked. Microglia are hostile to new connections. Synaptic consolidation is impaired. The vagal brake has failed, allowing inflammation to become self-sustaining.

This explains the lock. Why patterns can't shift despite perfect understanding.

But there's a third level of collapse we haven't yet examined: the void.

Inflammation doesn't just block rewiring (making change impossible). It also progressively exhausts the dopamine system, explaining why even when the lock could theoretically be opened, nothing feels worth doing.

James's "frozen" state isn't just about inability to change. It's about the complete collapse of incentive salience, the brain's capacity to register anything as worth pursuing. Marcus from SLM 3, still hitting his goals but feeling nothing? Same mechanism.

This is pursuit-reward decoupling, and it represents the third component of the Signal Loss Model. The complete SLM framework requires understanding all three mechanisms:

Untethered cognition (simulation) (SLM 2): Cognitive architecture decouples from reality when external feedback fails
Neuroimmune dysregulation (SLM 4): Neuroplasticity suppression prevents rewiring
Pursuit-reward decoupling (SLM 5): Dopamine collapse removes motivational pull toward change

These aren't separate problems requiring separate solutions. They're a self-reinforcing system: Uncalibrated simulation → chronic stress → inflammation → reward collapse → further internalization → more simulation decoupling → deeper inflammatory lock-in.

Each mechanism makes the others worse. Each mechanism must be addressed for lasting change to be possible.

Understanding the inflammatory component clarifies why traditional interventions fail when the biology is locked, what neuroplastic window therapies must accomplish during that brief period when change is biologically possible, and how integration architecture prevents the jailer from returning.

In SLM 5: When Nothing Feels Worth Doing, we turn to the reward system, and why "trying harder" not only doesn't work, but makes the collapse worse. We'll examine how sustained cortisol elevation (from chronic stress) downregulates dopamine receptors in the ventral striatum, causing the external world to lose motivational pull. We'll show how this interacts with inflammatory processes to create a specific phenomenology: you're no longer just stuck, you're empty.

References by Phase

Phase I: The Sentencing

Ablasser, Andrea, and Zhijian J. Chen. 2019. “cGAS in Action: Expanding Roles in Immunity and Inflammation.” Science (New York, N.Y.) 363 (6431): eaat8657.

Coppé, Jean-Philippe, Christopher K. Patil, Francis Rodier, et al. 2008. “Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the P53 Tumor Suppressor.” PLoS Biology 6 (12): 2853–68.

Franceschi, C., M. Bonafè, S. Valensin, et al. 2000. “Inflamm-Aging. An Evolutionary Perspective on Immunosenescence.” Annals of the New York Academy of Sciences 908 (June): 244–54.

Furman, David, Judith Campisi, Eric Verdin, et al. 2019. “Chronic Inflammation in the Etiology of Disease across the Life Span.” Nature Medicine 25 (12): 1822–32.

Glück, Selene, Baptiste Guey, Muhammet Fatih Gulen, et al. 2017. “Innate Immune Sensing of Cytosolic Chromatin Fragments through cGAS Promotes Senescence.” Nature Cell Biology 19 (9): 1061–70.

Hu, Huiqing, Ruxing Zhao, Qin He, et al. 2022. “cGAS-STING Mediates Cytoplasmic Mitochondrial-DNA-Induced Inflammatory Signal Transduction during Accelerated Senescence of Pancreatic β-Cells Induced by Metabolic Stress.” The FASEB Journal 36 (5): e22266.

Kosslyn, S. M., A. Pascual-Leone, O. Felician, et al. 1999. “The Role of Area 17 in Visual Imagery: Convergent Evidence from PET and rTMS.” Science 284 (5411): 167–70.

Lee, Hong-Gyun, and Francisco J. Quintana. 2025. “NR3C1 Limits the Imprinting of Astrocyte Epigenetic Inflammatory Memory Early in Life.” Nature Communications 16 (1): 8302.

Lee, Hong-Gyun, Joseph M. Rone, Zhaorong Li, et al. 2024. “Disease-Associated Astrocyte Epigenetic Memory Promotes CNS Pathology.” Nature 627 (8005): 865–72.

McEwen, Bruce S. 2007. “Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain.” Physiological Reviews 87 (3): 873–904.

Park, Seongwan, Hyeonji Park, Youkyeong Gloria Byun, et al. 2025. “NR3C1-Mediated Epigenetic Regulation Suppresses Astrocytic Immune Responses in Mice.” Nature Communications 16 (1): 8330.

Picard, Martin, and Bruce S. McEwen. 2018. “Psychological Stress and Mitochondria: A Systematic Review.” Psychosomatic Medicine 80 (2): 141–53.

West, A. Phillip, William Khoury-Hanold, Matthew Staron, et al. 2015. “Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response.” Nature 520 (7548): 553–57.

Phase II & III: The Lock & The Architecture

Calabrese, Francesca, Andrea C. Rossetti, Giorgio Racagni, Peter Gass, Marco A. Riva, and Raffaella Molteni. 2014. “Brain-Derived Neurotrophic Factor: A Bridge between Inflammation and Neuroplasticity.” Frontiers in Cellular Neuroscience 8: 430.

Dantzer, Robert, Jason C. O’Connor, Gregory G. Freund, Rodney W. Johnson, and Keith W. Kelley. 2008. “From Inflammation to Sickness and Depression: When the Immune System Subjugates the Brain.” Nature Reviews. Neuroscience 9 (1): 46–56.

Felger, J. C., and F. E. Lotrich. 2013. “Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications.” Neuroscience 246 (August): 199–229.

Felger, Jennifer C., and Andrew H. Miller. 2012. “Cytokine Effects on the Basal Ganglia and Dopamine Function: The Subcortical Source of Inflammatory Malaise.” Frontiers in Neuroendocrinology 33 (3): 315–27.

Koo, Ja Wook, and Ronald S. Duman. 2008. “IL-1β Is an Essential Mediator of the Antineurogenic and Anhedonic Effects of Stress.” Proceedings of the National Academy of Sciences 105 (2): 751–56.

Lucassen, Paul J., Jens Pruessner, Nuno Sousa, et al. 2014. “Neuropathology of Stress.” Acta Neuropathologica 127 (1): 109–35.

Miller, Andrew H., and Charles L. Raison. 2016. “The Role of Inflammation in Depression: From Evolutionary Imperative to Modern Treatment Target.” Nature Reviews. Immunology 16 (1): 22–34.

Pickering, Mark, and John J. O’Connor. 2007. “Pro-Inflammatory Cytokines and Their Effects in the Dentate Gyrus.” In Progress in Brain Research, vol. 163. Elsevier.

Rothhammer, Veit, Davis M. Borucki, Emily C. Tjon, et al. 2018. “Microglial Control of Astrocytes in Response to Microbial Metabolites.” Nature 557 (7707): 724–28.

Rothhammer, Veit, Ivan D. Mascanfroni, Lukas Bunse, et al. 2016. “Type I Interferons and Microbial Metabolites of Tryptophan Modulate Astrocyte Activity and Central Nervous System Inflammation via the Aryl Hydrocarbon Receptor.” Nature Medicine 22 (6): 586–97.

Schwarcz, Robert, John P. Bruno, Paul J. Muchowski, and Hui-Qiu Wu. 2012. “Kynurenines in the Mammalian Brain: When Physiology Meets Pathology.” Nature Reviews. Neuroscience 13 (7): 465–77.

Videbech, Poul, and Barbara Ravnkilde. 2004. “Hippocampal Volume and Depression: A Meta-Analysis of MRI Studies.” The American Journal of Psychiatry 161 (11): 1957–66.

Yirmiya, Raz, and Inbal Goshen. 2011. “Immune Modulation of Learning, Memory, Neural Plasticity and Neurogenesis.” Brain, Behavior, and Immunity 25 (2): 181–213.

Phase IV: Clinical Failures

Björkholm, Carl, and Lisa M. Monteggia. 2016. “BDNF – a Key Transducer of Antidepressant Effects.” Neuropharmacology 102 (March): 72–79.

Britton, Willoughby B. 2019. “Can Mindfulness Be Too Much of a Good Thing? The Value of a Middle Way.” Current Opinion in Psychology 28 (August): 159–65.

Duman, Ronald S., and Lisa M. Monteggia. 2006. “A Neurotrophic Model for Stress-Related Mood Disorders.” Biological Psychiatry 59 (12): 1116–27.

Gleeson, Michael, Nicolette C. Bishop, David J. Stensel, Martin R. Lindley, Sarabjit S. Mastana, and Myra A. Nimmo. 2011. “The Anti-Inflammatory Effects of Exercise: Mechanisms and Implications for the Prevention and Treatment of Disease.” Nature Reviews. Immunology 11 (9): 607–15.

Haroon, Ebrahim, Alexander W. Daguanno, Bobbi J. Woolwine, et al. 2018. “Antidepressant Treatment Resistance Is Associated with Increased Inflammatory Markers in Patients with Major Depressive Disorder.” Psychoneuroendocrinology 95 (September): 43–49.

Irwin, Michael R. 2015. “Why Sleep Is Important for Health: A Psychoneuroimmunology Perspective.” Annual Review of Psychology 66 (1): 143–72.

Rush, A. John, Madhukar H. Trivedi, Stephen R. Wisniewski, et al. 2006. “Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report.” American Journal of Psychiatry163 (11): 1905–17.

Tang, Yi-Yuan, Britta K. Hölzel, and Michael I. Posner. 2015. “The Neuroscience of Mindfulness Meditation.” Nature Reviews Neuroscience 16 (4): 213–25.

Phase V & VI: Vagal Brake & Reset

Bonnelle, Valerie, Amanda Feilding, Fernando E. Rosas, David J. Nutt, Robin L. Carhart-Harris, and Christopher Timmermann. 2024. “Autonomic Nervous System Activity Correlates with Peak Experiences Induced by DMT and Predicts Increases in Well-Being.” Journal of Psychopharmacology (Oxford, England) 38 (10): 887–96.

Browning, Kirsteen N., and R. Alberto Travagli. 2014. “Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions.” Comprehensive Physiology 4 (4): 1339–68.

Flanagan, Thomas W., and Charles D. Nichols. 2018. “Psychedelics as Anti-Inflammatory Agents.” International Review of Psychiatry (Abingdon, England) 30 (4): 363–75.

Gallowitsch‐Puerta, Margot, and Kevin J. Tracey. 2005. “Immunologic Role of the Cholinergic Anti‐Inflammatory Pathway and the Nicotinic Acetylcholine Α7 Receptor.” Annals of the New York Academy of Sciences 1062 (1): 209–19.

Hasler, Felix, Ulrike Grimberg, Marco A. Benz, Theo Huber, and Franz X. Vollenweider. 2004. “Acute Psychological and Physiological Effects of Psilocybin in Healthy Humans: A Double-Blind, Placebo-Controlled Dose-Effect Study.” Psychopharmacology 172 (2): 145–56.

Kemp, Andrew H., and Daniel S. Quintana. 2013. “The Relationship between Mental and Physical Health: Insights from the Study of Heart Rate Variability.” International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 89 (3): 288–96.

Pavlov, Valentin A., and Kevin J. Tracey. 2005. “The Cholinergic Anti-Inflammatory Pathway.” Brain, Behavior, and Immunity 19 (6): 493–99.

Porges, Stephen W. 2011. The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-Regulation. W. W. Norton & Company

Rosas, Fernando E., Pedro A. M. Mediano, Christopher Timmermann, et al. 2023. “The Entropic Heart: Tracking the Psychedelic State via Heart Rate Dynamics.” Preprint, Physiology, November 9.

Szabo, Attila. 2015. “Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.” Frontiers in Immunology 6: 358.

Thayer, Julian F., and Richard D. Lane. 2009. “Claude Bernard and the Heart-Brain Connection: Further Elaboration of a Model of Neurovisceral Integration.” Neuroscience and Biobehavioral Reviews 33 (2): 81–88.

Tracey, Kevin J. 2002. “The Inflammatory Reflex.” Nature 420 (6917): 853–59.

Wang, Hong, Man Yu, Mahendar Ochani, et al. 2003. “Nicotinic Acetylcholine Receptor Α7 Subunit Is an Essential Regulator of Inflammation.” Nature 421 (6921): 384–88.

Phase VII: Integration

Eisenberger, Naomi I., and Steve W. Cole. 2012. “Social Neuroscience and Health: Neurophysiological Mechanisms Linking Social Ties with Physical Health.” Nature Neuroscience 15 (5): 669–74.

Gerritsen, Roderik J. S., and Guido P. H. Band. 2018. “Breath of Life: The Respiratory Vagal Stimulation Model of Contemplative Activity.” Frontiers in Human Neuroscience 12: 397.

Hobson, Nicholas M., Juliana Schroeder, Jane L. Risen, Dimitris Xygalatas, and Michael Inzlicht. 2018. “The Psychology of Rituals: An Integrative Review and Process-Based Framework.” Personality and Social Psychology Review 22 (3): 260–84.

Kok, Bethany E., Kimberly A. Coffey, Michael A. Cohn, et al. 2013. “How Positive Emotions Build Physical Health: Perceived Positive Social Connections Account for the Upward Spiral between Positive Emotions and Vagal Tone.” Psychological Science 24 (7): 1123–32.

Payne, Peter, Peter A. Levine, and Mardi A. Crane-Godreau. 2015. “Somatic Experiencing: Using Interoception and Proprioception as Core Elements of Trauma Therapy.” Frontiers in Psychology 6 (February): 93.

Porges, Stephen W. 2011. The Polyvagal Theory: Neurophysiological Foundations of Emotions, Attachment, Communication, and Self-Regulation. W. W. Norton & Company.

van der Kolk, Bessel A. 2015. The Body Keeps the Score: Brain, Mind and Body in the Healing of Trauma. Penguin Books.

Essays on treatment resistance, altered states, and the conditions under which change becomes possible.